Palvella Therapeutics (PVLA) Change in Account Payables (2014 - 2026)
Palvella Therapeutics' (PVLA) quarterly Change in Account Payables came in at $851000.0 in Q1 2026, down 24.29% year-on-year from $1.1 million in Q1 2025, and down 26.38% on a QoQ basis from $1.2 million in Q4 2025.
Palvella Therapeutics (PVLA) Change in Account Payables (2014 - 2026) Analysis & Trends
Palvella Therapeutics (PVLA) has 7 years of Change in Account Payables data on file, last reported at $851000.0 in Q1 2026.
- On a quarterly basis, Change in Account Payables fell 24.29% year-over-year to $851000.0 in Q1 2026; TTM through Mar 2026 was $987000.0, a 69.88% decrease from a year earlier, with the FY2025 full-year figure at $1.3 million, down 43.7% from the prior year.
- Change in Account Payables for Q1 2026 stood at $851000.0, down from $1.2 million in the prior quarter.
- Over the last five years, Change in Account Payables for PVLA reached as high as $1.7 million in Q3 2024 and fell as low as -$1.1 million in Q3 2025.
- Historically, Change in Account Payables has averaged $483222.2 across 3 years, with a median of $425000.0 in 2024.
- On a YoY basis, Change in Account Payables climbed as much as 2588.37% in 2025 and fell as far as 167.42% in 2025.
- Year by year, Change in Account Payables stood at $43000.0 in 2024, then soared by 2588.37% to $1.2 million in 2025, then dropped by 26.38% to $851000.0 in 2026.
- Per Business Quant data, the three most recent Change in Account Payables figures were $851000.0 in Q1 2026, $1.2 million in Q4 2025, and -$1.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Palvella Therapeutics | 318.78 Mn | 56.92 Mn | - | 851,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 851,000.00 |
| Mar 31, 2026 | 851,000.00 |
| Dec 31, 2025 | 1.16 Mn |
| Dec 31, 2025 | 1.16 Mn |
| Sep 30, 2025 | -1.14 Mn |
| Sep 30, 2025 | -1.14 Mn |
| Jun 30, 2025 | 116,000.00 |
| Jun 30, 2025 | 116,000.00 |
| Mar 31, 2025 | 1.12 Mn |
| Mar 31, 2025 | 1.12 Mn |
| Dec 31, 2024 | 43,000.00 |
| Dec 31, 2024 | 43,000.00 |
| Sep 30, 2024 | 1.69 Mn |
| Sep 30, 2024 | 1.69 Mn |
| Jun 30, 2024 | 425,000.00 |
| Jun 30, 2024 | 425,000.00 |
| Mar 31, 2024 | 85,000.00 |
| Mar 31, 2024 | 85,000.00 |
| Dec 31, 2017 | -186,768.00 |
| Dec 31, 2017 | -186,768.00 |